BRANDI RUFFO: Open Payments
NPI 1770954257 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 32 payments from 9 companies in 2025. Trend: 2023 $1,245 · 2024 $1,589 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $166 |
| PFIZER INC. | 5 | $92 |
| ABBVIE INC. | 4 | $73 |
| Abbott Laboratories | 3 | $65 |
| Lilly USA, LLC | 3 | $44 |
| Exact Sciences Corporation | 3 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Esperion Therapeutics, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: NURTEC ODT, Ozempic, FREESTYLE LIBRE 3, Rybelsus, MOUNJARO, VRAYLAR, Wegovy, NEXLETOL.
Industry payments across SC — which companies pay providers there.
